Selected article for: "case infection and global public health"
Author: Vlachakis, Dimitrios; Papakonstantinou, Eleni; Mitsis, Thanasis; Pierouli, Katerina; Diakou, Io; Chrousos, George; Bacopoulou, Flora
Title: Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic
  • Cord-id: rxjahqwh
  • Document date: 2020_10_8
    • ID: rxjahqwh
    Snippet: The novel coronavirus SARS-CoV-2 has emerged as a severe threat against public health and global economies. COVID-19, the disease caused by this virus, is highly contagious and has led to an ongoing pandemic. SARS-CoV-2 affects, mainly, the respiratory system, with most severe cases primarily showcasing acute respiratory distress syndrome. Currently, no targeted therapy exists, and since the number of infections and death toll keeps rising, it has become a necessity to study possible therapeutic
    Document: The novel coronavirus SARS-CoV-2 has emerged as a severe threat against public health and global economies. COVID-19, the disease caused by this virus, is highly contagious and has led to an ongoing pandemic. SARS-CoV-2 affects, mainly, the respiratory system, with most severe cases primarily showcasing acute respiratory distress syndrome. Currently, no targeted therapy exists, and since the number of infections and death toll keeps rising, it has become a necessity to study possible therapeutic targets. Antiviral drugs can target various stages of the viral infection, and in the case of SARS-CoV-2, both structural and non-structural proteins have been proposed as potential drug targets. This review focuses on the most researched SARS-CoV-2 proteins, their structure, function, and possible therapeutic approaches.

    Search related documents:
    Co phrase search for related documents
    • ace inhibitor and active site: 1, 2
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • acid binding and action mechanism: 1, 2, 3, 4, 5
    • acid binding and activation contribute: 1
    • acid binding and active compound: 1
    • acid binding and active metabolite: 1, 2
    • acid binding and active site: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acid binding and activity type: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acid binding and acute ards respiratory distress syndrome: 1
    • acid derivative and action mechanism: 1, 2, 3, 4, 5
    • acid derivative and active compound: 1
    • acid derivative and active metabolite: 1
    • acid derivative and active site: 1, 2
    • acid derivative and acute ards respiratory distress syndrome: 1
    • action mechanism and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • activation contribute and acute ards respiratory distress syndrome: 1, 2, 3
    • active center and acute ards respiratory distress syndrome: 1
    • active compound and acute ards respiratory distress syndrome: 1, 2
    • active metabolite and acute ards respiratory distress syndrome: 1, 2, 3